Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb 7:26:101386.
doi: 10.1016/j.ajoc.2022.101386. eCollection 2022 Jun.

Minocycline-induced scleral pigmentation

Sara Al Hussein Al Awamlh  1 , Kenneth J Taubenslag  1 , Sapna Gangaputra  1
Affiliations

Minocycline-induced scleral pigmentation

Sara Al Hussein Al Awamlh et al. Am J Ophthalmol Case Rep. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

We declare no competing interests.

Figures

Fig. 1
Fig. 1
Minocycline-induced scleral pigmentation. Image of the left eye in primary gaze showing interpalpebral grayish scleral pigmentation and a nasal pterygium (A). Image of the left eye in right gaze showing noticeable decrease in pigmentation 2 months following initial presentation (B). Anterior segment OCT of the left eye showing normal scleral thickness (C).
See this image and copyright information in PMC

References

    1. Maloney S.M., Williams B.K., Jr., Shields C.L. Long-term minocycline therapy with scleral pigmentation simulating melanocytosis. JAMA Ophthalmol. Nov 1 2018;136(11) doi: 10.1001/jamaophthalmol.2018.3088. - DOI - PubMed
    1. Law S. Minocycline-induced blue sclera and skin hyperpigmentation. BMJ Case Rep. Nov. 2021;18(11):14. doi: 10.1136/bcr-2021-245508. - DOI - PMC - PubMed
    1. Haskes C., Shea M., Imondi D. Minocycline-induced scleral and dermal hyperpigmentation. Optom Vis Sci. Mar. 2017;94(3):436–442. doi: 10.1097/opx.0000000000001024. - DOI - PubMed

LinkOut - more resources